다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

PHVS

Pharvaris NV (PHVS)

Pharvaris NV

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:PHVS

1 2 3 4 5 6 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/13	19:50	GlobeNewswire Inc.	Pharvaris to Present Clinical and Nonclinical Data at Upcoming Congresses	NASDAQ:PHVS	Pharvaris NV
2024/05/09	05:11	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PHVS	Pharvaris NV
2024/05/09	05:10	GlobeNewswire Inc.	Pharvaris Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:PHVS	Pharvaris NV
2024/04/11	05:10	GlobeNewswire Inc.	Pharvaris Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:PHVS	Pharvaris NV
2024/04/11	05:08	GlobeNewswire Inc.	Pharvaris Appoints David Nassif, J.D., as Chief Financial Officer	NASDAQ:PHVS	Pharvaris NV
2024/04/04	19:50	GlobeNewswire Inc.	Pharvaris to Present Deucrictibant Clinical Data at the CIIC Spring 2024 Conference	NASDAQ:PHVS	Pharvaris NV
2024/03/18	19:50	GlobeNewswire Inc.	Pharvaris Announces Phase 3 Clinical Study Design for Recently Initiated RAPIDe-3 Study, and Presents Quality-of-Life Improvement and Caregiver Behavior Data at Two Recent HAE Congresses	NASDAQ:PHVS	Pharvaris NV
2024/03/12	02:51	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PHVS	Pharvaris NV
2024/03/07	06:40	Edgar (US Regulatory)	Form F-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers	NASDAQ:PHVS	Pharvaris NV
2024/03/07	06:15	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PHVS	Pharvaris NV
2024/03/06	20:50	GlobeNewswire Inc.	Pharvaris to Present Deucrictibant Clinical Data at Upcoming Congresses	NASDAQ:PHVS	Pharvaris NV
2024/03/05	20:50	GlobeNewswire Inc.	Pharvaris to Participate in the Leerink Global Biopharma Conference 2024	NASDAQ:PHVS	Pharvaris NV
2024/02/22	20:50	GlobeNewswire Inc.	Positive Results from CHAPTER-1 Phase 2 Study of Deucrictibant for the Prophylactic Treatment of HAE Attacks to be Presented at AAAAI 2024 Annual Meeting	NASDAQ:PHVS	Pharvaris NV
2024/02/16	20:51	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PHVS	Pharvaris NV
2024/02/16	20:50	GlobeNewswire Inc.	Pharvaris Announces Extraordinary Meeting of Shareholders	NASDAQ:PHVS	Pharvaris NV
2024/02/08	06:01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PHVS	Pharvaris NV
2024/02/02	06:46	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PHVS	Pharvaris NV
2024/01/26	20:50	GlobeNewswire Inc.	Pharvaris to Present at the WSAAI Annual Meeting 2024	NASDAQ:PHVS	Pharvaris NV
2024/01/22	21:35	Dow Jones News	Pharvaris Says FDA Lifted Clinical Hold on Application for Deucrictibant	NASDAQ:PHVS	Pharvaris NV
2024/01/22	20:51	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PHVS	Pharvaris NV
2024/01/22	20:50	GlobeNewswire Inc.	Pharvaris Announces FDA Lifting of the Clinical Hold of Deucrictibant for the Prophylactic Treatment of HAE Attacks	NASDAQ:PHVS	Pharvaris NV
2024/01/08	21:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PHVS	Pharvaris NV
2024/01/05	20:50	GlobeNewswire Inc.	Pharvaris Provides Business Update and Outlines 2024 Strategic Priorities	NASDAQ:PHVS	Pharvaris NV
2024/01/03	06:29	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PHVS	Pharvaris NV
2023/12/09	08:00	GlobeNewswire Inc.	Pharvaris Presents Deucrictibant Clinical Data and Analysis of Endpoints for Trials of On-demand Treatment of HAE at the GA²LEN UCARE Conference 2023	NASDAQ:PHVS	Pharvaris NV
2023/12/09	06:50	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PHVS	Pharvaris NV
2023/12/08	06:17	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:PHVS	Pharvaris NV
2023/12/07	06:36	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PHVS	Pharvaris NV
2023/12/06	21:08	Edgar (US Regulatory)	Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses	NASDAQ:PHVS	Pharvaris NV
2023/12/06	21:02	GlobeNewswire Inc.	Pharvaris Announces Pricing of $300 Million Underwritten Offering of Ordinary Shares and Pre-funded Warrants	NASDAQ:PHVS	Pharvaris NV

검색 관련기사 보기:NASDAQ:PHVS

1 2 3 4 5 6 다음 >>

Exchange Listed Funds Tr...

JPM USD Corp Bond Resear...

Quadpack Industries

Rari Governance Token

Direxion Daily AMZN Bull...

Johnson And Johnson

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관